10. SEGMENTS (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||||
---|---|---|---|---|---|---|---|
Jun. 30, 2019 |
Mar. 31, 2019 |
Jun. 30, 2018 |
Mar. 31, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
Dec. 31, 2018 |
|
Revenues | $ 6,560,942 | $ 4,656,550 | $ 10,089,531 | $ 8,698,556 | |||
Cost of product revenue | 10,491,236 | 9,645,662 | 19,896,415 | 21,888,410 | |||
Loss from operations | (11,338,674) | (13,417,381) | (24,547,090) | (29,949,884) | |||
Interest and other (expense) income, net | (1,873,198) | (1,330,450) | (3,297,663) | (2,620,089) | |||
Gain on transfer of plasma center assets | 0 | 0 | 11,527,421 | 0 | |||
Loss on extinguishment of debt | 0 | 0 | (9,962,495) | 0 | |||
Net (loss) income | (13,211,872) | $ (13,067,955) | (14,747,831) | $ (17,822,142) | (26,279,827) | (32,569,973) | |
Purchase of property and equipment | 245,675 | 1,046,375 | |||||
Depreciation and amortization | 806,093 | 845,899 | 1,611,422 | 1,675,439 | |||
Total assets | 143,274,120 | 117,751,992 | 143,274,120 | 117,751,992 | $ 88,876,521 | ||
ADMA BioManufacturing | |||||||
Revenues | 4,002,445 | 2,144,724 | 5,346,428 | 3,810,967 | |||
Cost of product revenue | 8,170,381 | 7,965,681 | 16,110,727 | 18,663,323 | |||
Loss from operations | (8,671,783) | (9,918,243) | (19,292,591) | (22,642,709) | |||
Interest and other (expense) income, net | (246,603) | (237,161) | (416,216) | (477,214) | |||
Gain on transfer of plasma center assets | 0 | ||||||
Loss on extinguishment of debt | 0 | ||||||
Net (loss) income | (8,918,386) | (10,155,404) | (19,708,807) | (23,119,923) | |||
Purchase of property and equipment | 224,440 | 591,665 | |||||
Depreciation and amortization | 688,848 | 639,300 | 1,376,240 | 1,271,131 | |||
Total assets | 67,236,416 | 54,297,915 | 67,236,416 | 54,297,915 | |||
Plasma Collection Centers | |||||||
Revenues | 2,522,788 | 2,476,117 | 4,671,686 | 4,816,172 | |||
Cost of product revenue | 2,320,855 | 1,679,981 | 3,785,688 | 3,225,087 | |||
Loss from operations | (392,181) | (941,993) | (362,601) | (1,980,817) | |||
Interest and other (expense) income, net | (59) | (436) | 13,560 | (871) | |||
Gain on transfer of plasma center assets | 11,527,421 | ||||||
Loss on extinguishment of debt | 0 | ||||||
Net (loss) income | (392,240) | (942,429) | 11,178,380 | (1,981,688) | |||
Purchase of property and equipment | 21,235 | 454,710 | |||||
Depreciation and amortization | 113,958 | 200,598 | 228,199 | 389,512 | |||
Total assets | 3,835,999 | 5,438,645 | 3,835,999 | 5,438,645 | |||
Corporate | |||||||
Revenues | 35,709 | 35,709 | 71,417 | 71,417 | |||
Cost of product revenue | 0 | 0 | 0 | 0 | |||
Loss from operations | (2,274,710) | (2,557,145) | (4,891,898) | (5,326,358) | |||
Interest and other (expense) income, net | (1,626,536) | (1,092,853) | (2,895,007) | (2,142,004) | |||
Gain on transfer of plasma center assets | 0 | ||||||
Loss on extinguishment of debt | (9,962,495) | ||||||
Net (loss) income | (3,901,246) | (3,649,998) | (17,749,400) | (7,468,362) | |||
Purchase of property and equipment | 0 | 0 | |||||
Depreciation and amortization | 3,287 | 6,001 | 6,983 | 14,796 | |||
Total assets | $ 72,201,705 | $ 58,015,432 | $ 72,201,705 | $ 58,015,432 |